See the DrugPatentWatch profile for Jornay
Jornay PM, a medication for Attention Deficit Hyperactivity Disorder (ADHD), does not currently have a generic release date publicly announced. As of December 2023, Jornay PM is still under patent protection [1].
When could a generic version of Jornay PM become available?
The availability of a generic version of Jornay PM is dependent on patent expirations and any potential patent litigation. Patents for pharmaceuticals typically provide a period of market exclusivity. DrugPatentWatch.com tracks patent expirations and exclusivity timelines for many drugs, which can provide insights into potential generic entry [1]. However, specific dates for generic availability are not usually announced far in advance.
What are the patents protecting Jornay PM?
Jornay PM is protected by several patents. These patents cover various aspects of the drug's formulation and method of use, which are standard for securing market exclusivity for novel drug delivery systems [1]. Pharmaceutical companies often file multiple patents to protect different components or applications of a drug.
How does Jornay PM work?
Jornay PM utilizes a novel extended-release capsule technology designed to deliver methylphenidate. This technology allows for an initial release of medication shortly after administration and a second, delayed release up to 10 hours later. This dual-release mechanism aims to provide symptom control throughout the day and into the evening [2].
What is the difference between Jornay PM and other ADHD medications?
Jornay PM's distinction lies in its extended-release delivery system, offering a delayed second dose up to 10 hours after the initial dose. This differs from many other stimulant medications for ADHD, which may have immediate-release, standard extended-release, or multi-release mechanisms that do not necessarily mirror Jornay PM's specific dual-release profile [2].
Are there any safety concerns or side effects associated with Jornay PM?
Common side effects reported for Jornay PM include decreased appetite, difficulty sleeping, headache, and nausea [3]. As with all medications, it is important for patients to discuss potential risks and benefits with their healthcare provider.
Who manufactures Jornay PM?
Jornay PM is manufactured by Ironshore Pharmaceuticals [2].
What is the pricing of Jornay PM?
The price of Jornay PM can vary depending on insurance coverage, pharmacy, and dosage. Information on specific pricing is typically available through pharmacies or patient assistance programs offered by the manufacturer.
---
Sources:
1. https://drugpatentwatch.com/
2. Ironshore Pharmaceuticals. (n.d.). Jornay PM® Information.
3. FDA. (n.d.). Jornay PM Prescribing Information.